Hypercalcemia on a Thiazide: Surgery or Observation?
A 61-year-old woman is referred for evaluation of incidentally discovered hypercalcemia. Two years ago serum calcium was 10.1 mg/dL (reference 8.6–10.2). Six months ago, while starting hydrochlorothiazide 25 mg daily for hypertension, calcium was 10.8 mg/dL. Today, still on the thiazide, calcium is 11.2 mg/dL, albumin 4.0 g/dL, phosphorus 2.9 mg/dL, creatinine 0.9 mg/dL, 25-hydroxyvitamin D 24 ng/mL, and intact PTH 58 pg/mL (reference 15–65). She takes no calcium supplements, has no history of kidney stones, and has no symptoms other than mild fatigue. A DXA from last year shows a lumbar spine T-score of −2.6 and a femoral neck T-score of −2.1. She asks whether she needs surgery or can simply be monitored.
1. How do you interpret the calcium, PTH, and thiazide? What is the next diagnostic step?
Read the worked answer
The PTH of 58 pg/mL is within the reference range, but in the presence of hypercalcemia it is inappropriately non-suppressed, indicating PTH-dependent hypercalcemia. The differential includes primary hyperparathyroidism, familial hypocalciuric hypercalcemia, thiazide effect, and lithium use. Thiazides reduce renal calcium excretion and can unmask or worsen primary hyperparathyroidism, so the diagnosis cannot be firmly made while she is taking hydrochlorothiazide. Stop the thiazide, switch to an alternative antihypertensive, and recheck calcium, phosphorus, creatinine, and PTH in 4–8 weeks. Also obtain a 24-hour urine calcium to calculate the calcium-to-creatinine clearance ratio, which screens for familial hypocalciuric hypercalcemia, and check lithium if there is any exposure history. Her 25-hydroxyvitamin D of 24 ng/mL is borderline; replete cautiously to about 20–30 ng/mL. If calcium normalizes off the thiazide, the thiazide was the main driver; if hypercalcemia and elevated PTH persist, primary hyperparathyroidism is confirmed.
2. If primary hyperparathyroidism is confirmed after thiazide withdrawal, does she meet criteria for parathyroidectomy? Which criterion applies?
Read the worked answer
She meets at least one guideline criterion for parathyroidectomy: a DXA T-score of −2.5 or lower at any site, here the lumbar spine at −2.6. The other Fourth International Workshop criteria are age under 50 (she is 61), serum calcium more than 1.0 mg/dL above the upper limit of normal (11.2 versus 10.2 is exactly 1.0, not more than 1.0), GFR below 60 (hers is normal), nephrolithiasis or nephrocalcinosis (absent), and 24-hour urinary calcium above 400 mg (not yet measured). Because she meets the skeletal criterion, surgery is recommended, not merely optional. Refer her to an experienced parathyroid surgeon. Localization studies-neck ultrasound plus sestamibi or four-dimensional CT-should be obtained only after the biochemical diagnosis is secure and surgery is planned; they are not diagnostic tests for primary hyperparathyroidism. If she elects observation, document that this is a preference-sensitive decision against guideline advice.
3. If she declines surgery, outline monitoring and medication adjustments.
Read the worked answer
Observation is acceptable only if she understands it is not curative. Monitor serum calcium and creatinine annually, 24-hour urine calcium, and DXA every 1–2 years; obtain renal imaging if stones are suspected. Switch hydrochlorothiazide to an alternative antihypertensive such as an ACE inhibitor, angiotensin-receptor blocker, or calcium-channel blocker, because thiazides raise calcium and complicate monitoring. Replete vitamin D to a 25-hydroxyvitamin D level of about 20–30 ng/mL; avoid high-dose supplementation that can worsen hypercalcemia. Encourage hydration and avoid immobilization. Bisphosphonates may be used if osteoporosis is the main concern and surgery is declined, but they do not correct PTH excess. Cinacalcet lowers calcium but does not improve bone density or reduce stone risk. Counsel on symptoms of severe hypercalcemia and set a threshold for reconsidering surgery.